Skip to main content
. 2021 Aug 24;18(4):2651–2663. doi: 10.1007/s13311-021-01098-3

Table 2.

Baseline characteristics

Variable All participants (n = 70) Control (n = 20) Treatment (n = 50) p value
Age, y 49.2 ± 11.2 44.8 ± 10.3 50.9 ± 11.1 0.063
Female gender, % 49 (70.0) 14 (70.0) 34 (68.0) 0.987
Marital status, 0.228
Single 29 (41.4) 7 (35.0) 22 (44.0)
Married/cohabiting 31 (44.3) 9 (45.0) 22 (44.0)
Divorced/widowed 10 (14.3) 4 (20.0) 6 (12.0)
Education level, % 0.430
Never received education 1 (1.43) 0 (0.00) 1 (2.00)
Primary School level 2 (2.86) 0 (0.00) 2 (4.00)
Secondary School level 33 (47.1) 9 (45.0) 24 (48.0)
University level or higher 34 (48.6) 11 (55.0) 23 (46.0)
Occupation % 0.308
Professional 21 (30.0) 6 (30.0) 15 (30.0)
Non-professional 32 (45.7) 12 (60.0) 20 (40.0)
Technician 3 (4.29) 0 (0.00) 3 (6.0)
Non-technician 3 (4.29) 0 (0.00) 3 (6.0)
Housewife 8 (11.4) 1 (5.00) 7 (14.0)
Student 1 (1.43) 0 (0.00) 1 (2.00)
Other 2 (2.86) 1 (5.00) 1 (2.00)
Refuse to answer 0 (0.00) 0 (0.00) 0 (0.00)
Depression duration, y 10.8 ± 10.4 10.3 ± 8.48 12.4 ± 12.1 0.576
Antidepressant, % 0.365
Serotonin and norepinephrine reuptake inhibitors, SSRI 48 (68.6) 14 (70.0) 34 (68.0)
Serotonin and norepinephrine reuptake inhibitors, SNRI 9 (12.9) 3 (15.0) 6 (12.0)
Dopamine reuptake blocker 3 (0.04) 0 (0.00) 3 (0.06)
Othera 10 (0.14) 2 (0.10) 8 (0.16)
Alcohol drinker, %
Never 46 (65.7) 9 (45.00) 37 (74.0) 0.069
Occasional 24 (34.3) 11(55.0) 13 (26.0)
Frequent 0 (0.00) 0(0.00) 0 (0.00)
Smoker, %
Never 67 (95.7) 17 (85.0) 50 (100.00) 0.110
Occasional 2 (2.86) 2 (10.0) 0 (0.00)
Frequent 1 (1.43) 1 (5.00) 0 (0.00)
Drug abuser, % 0 (0.00) 0 (0.00) 0 (0.00) /
TCM diagnosis 0.102
Yang-Deficiency 7 (10.00) 1 (5.00) 6 (12.0)
Liver-Qi Stagnation 24 (34.3) 7 (35.0) 17 (34.0)
Both 39 (55.7) 12 (60.0) 27 (54.0)

a Other antidepressants such as noradrenergic antagonists, monoamine oxidase inhibitors, or tricyclic antidepressants